Imagin Medical (CSE: IME) (OTCQB: IMEXF), a surgical imaging company visualizing cancer in vital new ways starting with bladder cancer, has announced changes in its board of directors. The company has named Kayvon Namvar as chair of the audit committee and new board member, replacing Robin Atlas, MD, who has resigned. A principal at RNA Capital Advisors, a financial and strategic advisory firm, Namvar also serves as vice president of finance & strategic analysis at Hawthorne Effect Inc., a healthcare technology company. Namvar brings a rich background in forecasting, valuation and transaction advisory support in the life sciences, healthcare and technology industries to his new role and responsibilities. Other changes to the board include Kevin Slawin, MD, Imagin’s lead investor and a leading uro-oncologist who joined the board last year, being appointed board chair. “As a urologist who cared for patients with cancer over a 25-year career as a professor and urological oncologic surgeon, I have an intimate knowledge of the field and of the needs of patients with prostate and bladder cancer,” said Imagin Medical chair Kevin Slawin in the press release. “Adding the board chairman position to my lead investor role in Imagin signifies my appreciation of Imagin’s advanced technology and the potential it may bring to the improvement in the care of these patients.”
To view the full press release, visit https://ibn.fm/RNqRZ
About Imagin Medical
Imagin Medical is a surgical imaging company focused on advancing new methods of visualizing cancer during minimally invasive procedures. The company believes its first product, the i/Blue(TM) Imaging System, with its proprietary optics and light sensors, will greatly increase the efficiency and accuracy of detecting cancer for removal, helping to reduce recurrence rates. The company’s initial focus is bladder cancer. For more information about the company, visit www.ImaginMedical.com.
NOTE TO INVESTORS: The latest news and updates relating to IMEXF are available in the company’s newsroom at https://ibn.fm/IMEXF
About InvestorWire
InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.
With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.
Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.
For more information, please visit https://www.InvestorWire.com
Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer
InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
Editor@InvestorWire.com
InvestorWire is part of the InvestorBrandNetwork.
